In recent years, the use of acetylcholinesterases (AChEs) in biosensor technology has gained enormous attention, in particular with respect to insecticide detection. The principle of biosensors using AChE as a biological recognition element is based on the inhibition of the enzyme's natural catalytic activity by the agent that is to be detected. The advanced understanding of the structure-function-relationship of AChEs serves as the basis for developing enzyme variants, which, compared to the wild type, show an increased inhibition efficiency at low insecticide concentrations and thus a higher sensitivity. This review describes different expression systems that have been used for the production of recombinant AChE. In addition, approaches to purify recombinant AChEs to a degree that is suitable for analytical applications will be elucidated as well as the various attempts that have been undertaken to increase the sensitivity of AChE to specified organophosphates and carbamates using sidedirected mutagenesis and employing the enzyme in different assay formats.
Introduction
Acetylcholinesterase (AChE, EC 3.1.1.7) plays a key role in cholinergic transmission by catalysing the rapid hydrolysis of the neurotransmitter acetylcholine into acetate and choline (Rosenberry, 1975) . The enzyme effectively terminates the chemical impulse at rates that are similar to a diffusion-controlled process allowing a rapid and repetitive response (Bazelyansky et al., 1986) . Inhibitors of AChE, such as organophosphates and carbamates, interfere with this process and may lead to a severe impairment of nerve functions or even death. Therefore, insect AChE is the biological target of predominant insecticides used in agriculture. AChE inhibitors are useful but at the same time pose severe environmental and health risks (Millard and Broomfield, 1995) . Consequently, there is a growing interest in faster and more sensitive detection systems. Methods traditionally used for the detection of insecticides are based on gas chromatography (GC) or high performance liquid chromatography (HPLC) coupled with mass selective detectors (MSD) (Martinez et al., 1992; Pylypiw, 1993) . As an alternative, acetylcholinesterase (AChE) inhibition tests, and the AChE-biosensors in particular, have been shown to be suitable for the detection of insecticides. The pioneering work of George G. Guilbault, focused on cholinesterase purification and inhibitor analysis (Guilbault et al., 1970a; Guilbault et al., 1970b; Guilbault et al., 1970c) , immobilization (Guilbault and Das, 1970) and assay development (Guilbault and Kramer, 1965; von Storp and Guilbault, 1972; Gibson and Guilbault, 1975; Guilbault and Iwase, 1976; Van Sant, 1986; Guilbault and Schmid, 1991; Huang et al., 1993) , has paved the way for many other groups involved in the development of different biosensor formats for neurotoxin detection.
Selected examples are shown in Table 1 .
AChE-based biosensors have a major drawback: they give a sum parameter of AChE-inhibition without any qualitative or quantitative information about the individual analytes, i.e. different AChE-inhibiting insecticides cannot be measured selectively.
One approach to solve this problem involves the application of multisensor arrays that are combined with the data processing of artificial neural networks. Genetically engineered cholinesterase variants with specific and high inhibition constants for the desired analytes are required for the compound-specific multianalyte detection.
The resolution of the three dimensional structure of Torpedo californica AChE using x-ray refraction (Sussman et al., 1991) , the elucidation of the structure-functionrelationship of AChEs probed by site-directed mutagenesis Ashani et al., 1995; Faerman et al., 1996) and the development of efficient expression systems for the production of larger amounts of recombinant AChEs all contributed to the use of this enzyme in analytical applications. Specific AChEs with an increased sensitivity towards different inhibitors could be developed by sidedirected mutagenesis and be used successfully for the detection of minute quantities of pesticides in environmental and food samples.
Functional expression of recombinant AChEs
A prerequisite for the commercialisation of biosensors is the availability of large amounts of extremely pure, functional and stable enzyme samples at low costs.
AChE can be purified from human or animal blood or from the electric organ of the electric eel. These sources are, however, limited and the purification is both time and cost intensive. To overcome this problem, AChEs of different origin have been cloned and functionally expressed in several systems. Active and correctly processed Bungarus fasciatus (Cousin et al., 1996a) , rat (Legay et al., 1993) , Torpedo marmorata (Duval et al., 1992b) and Electrophorus electricus (Simon and Massoulie, 1997) AChEs have been produced in COS cells, rat AChE in RBL cells (Coussen et al., 1995) and human AChE in HEK 293 cells (Velan et al., 1991b; Kronman et al., 1992) . However, these studies focus mainly on the development of an efficient mammalian cell system to provide an experimental tool for the detailed analysis of the catalytic mechanisms and structural properties of AChEs rather than on high yields of purified AChEs. The biosynthetic processes that lead to numerous different AChE forms have also been intensively investigated in these cell systems. The amounts of expressed protein in mammalian cells, however, were very low (Table 2) .
Production costs and the production of the enzymes on a larger scale prove to be major obstacles. AChEs from Torpedo californica (Radic et al., 1992) , Drosophila melanogaster (Chaabihi et al., 1994; Estrada-Mondaca et al., 1998) and rat brain could be actively expressed in satisfactory amounts in a baculovirus-insect cell system ( Table 2 ). The baculovirus system has severe limitations with respect to the production of larger amounts of protein, but seems to be very suitable for producing mutant recombinant AChEs. Attempts to express functional human (Fischer et al., 1993) or rat brain (Heim et al., 1998) 
AChE in
Escherichia coli failed because the expressed enzyme was accumulated in inclusion bodies as an inactive protein. Only a small amount of active AChE could be recovered by refolding and oxidation procedures. In addition, the recombinant human enzyme was unstable (Fischer et al., 1993) . Recently, Mor et al. described the expression of human AChE in transgenic tomato plants (Mor et al., 2001) . Active and stable AChE, which retains the kinetic characteristics of the native human enzyme, could be enriched in tomato plants and isolated from leaves and fruit. The functional expression and secretion into the medium of rat brain Heim et al., 1998) , Bungarus fasciatus and Nippostrongylus brasiliensis (Hussein et al., 1999) AChE could be achieved using the methylotrophic yeast Pichia pastoris and the ability of Pichia pastoris to synthesise and correctly process vertebrate AChEs could be shown. Further optimisation of the cultivation conditions and the possibility of performing fed-batch or continuous fermentation on a large scale renders Pichia pastoris one of the most promising expression systems with regard to the low-cost and high-yield production of recombinant AChEs. In addition, a rapid and efficient assay to screen active Pichia pastoris transformants using indoxylacetate as substrate was recently proposed (Villatte et al., 2001) . Different strategies to enhance the expression of AChE on the gene level were pursued. One strategy involves the examination of the expression of recombinant rat or Bungarus AChE in Pichia pastoris by exchanging the native signal peptides for yeast signal peptides or by introducing propeptides which do usually not exist in AChE . A second approach arose from the observation that highly homologous AChEs from different species are produced at markedly different levels in the same expression systems (Cousin et al., 1996a; Morel and Massoulie, 1997) . Rat/Bungarus and Bungarus/rat chimeras were expressed in COS cells (Morel and Massoulie, 2000) in order to elucidate the causes of the variability in the expression levels of different enzymes.
Purification of recombinant AChE
After the expression of recombinant AChE and especially AChE mutants in heterologous systems it is important to purify the enzyme rapidly in order to characterise its features and estimate its applicability in a biosensor. Two approaches are usually applied for the purification of the enzymes: ion exchange chromatography (Estrada-Mondaca and Fournier, 1998; Heim et al., 1998) and affinity chromatography (Estrada-Mondaca and Fournier, 1998; Heim et al., 1998; Villatte et al., 1998; Villatte et al., 2000) based on the chemical modification of the support with reversible AChE inhibitors (Massoulie and Bon, 1976; Ralston et al., 1983) or on the addition of a His-tag to the enzyme (Estrada-Mondaca and Fournier, 1998; Heim et al., 1998; Hussein et al., 1999; Hussein et al., 2000) .
Estrada-Mondaca and Fournier combined affinity chromatography (using procainamide as ligand) with anionic-exchange chromatography for the purification of Drosophila melanogaster AChE (DmAChE) after expression in baculovirus-infected cells (Estrada-Mondaca and Fournier, 1998) . The use of a diethylaminoethyl (DEAE)-Sepharose column after affinity purification allowed the separation of AChE from proteases that are co-extracted with the AChE. The use of a His-tagged variant of DmAChE for metal chelating affinity chromatography led to an extremely pure enzyme (purity > 95 %) that did not exhibit any protease activity. After expression in Drosophila Schneider Line2 cells, Harel et al. purified recombinant DmAChE in two purification cycles using acridinium resin (Rosenberry and Scoggin, 1984; Harel et al., 2000) . In the first purification round, purified DmAChE was eluted from the column by ligand competition using decamethonium with Triton X-100; in the second round no Triton X-100 was used. Dialysis was employed to remove decamethonium.
Because the elution with decamethonium only yielded a recovery rate of 1 % of the applied AChE-activity, Heim et al. eluted recombinant rat brain AChE (RbAChE) expressed in E. coli using acetylcholine iodide instead of decamethonium (Heim et al., 1998) . Two purification cycles resulted in a specific activity of 253 U/mg.
Purification of His-tagged AChE on a Ni-NTA affinity column yielded 8.4 mg purified enzyme. This amount corresponded to a calculated recovery yield of approximately 90 %. Hussein et al. purified recombinant AChE from the parasitic nematode Nippostrongylus brasiliensis with acridium affinity chromatography and by nickelchelating affinity chromatography (Hussein et al., 1999) . Acridium affinity chromatography yielded a considerably lower specific activity of the native enzyme (685 U/mg) than nickel-chelating chromatography of the recombinant enzyme (2080 U/mg). This was attributed to the residual binding of decamethonium to the native enzyme.
Protein engineering of AChE

Sequence and structure
AChEs have a remote sequence similarity with other esterases, especially butyrylcholinesterases, carboxylesterases and lipases (Cousin et al., 1996b Three residues (catalytic triad) are essential for the enzyme's activity: serine, histidine and glutamate (Rosenberry, 1975; Duval et al., 1992a) . This active site is located near the bottom of a 20 Å deep, narrow gorge that is lined with 14 conserved aromatic amino acids (Sussman et al., 1991; Saxena et al., 1997) . Substrates and inhibitors bind to three distinct binding sites 
Increased sensitivity towards insecticides by site-directed mutagenesis
Shafferman et al. were able to generate a large number of recombinant human acetylcholinesterase (HuAChE) mutants for use in mechanistic studies. Amino acids were identified which are important for maintaining the structural integrity of the enzyme (Velan et al., 1991a; Shafferman et al., 1992a) as well as residues that are involved in catalysis and interaction with various substrates and reversible inhibitors (Shafferman et al., 1992b; Ordentlich et al., 1993; Ordentlich et al., 1996) . The group also analysed the functional characteristics of the oxyanion hole in HuAChE (Ordentlich et al., 1998) . Substitutions in the acyl pocket led to an increase in sensitivity of human AChE towards three tested organophosphate inhibitors (Ordentlich et al., 1996) . Phenylalanine residues at position 295 and 297 were replaced by less bulky amino acids. The F295A mutant showed a 20-fold greater sensitivity towards paraoxon (Table 3 ). The introduction of valine at position 297 and leucine at position 297, in analogy to the corresponding positions in butyrylcholinesterase (BChE), led to a 25-fold increase in sensitivity to diisopropyl phosphorofluoridate (DFP). On the other hand, mutations of the hydrogen bond network residues Tyr-133, Glu-202, and Glu-450 led to a lower reactivity (up to a factor of 160) to paraoxon, DFP and diethyl phosphorofluoridate (DEFP).
Modifications in the oxyanion hole (G122A and G121A) led to a decrease in sensitivity to DFP, DEFP, and paraoxon by up to three orders of magnitude (Ordentlich et al., 1998) . The substitution of six aromatic amino acids in the active (Aldridge, 1950) ; E = enzyme, CX = carbamate or organophosphate compound, X = leaving group, C = remaining group, k 3 = decarbamylation rate constant and ki = bimolecular rate constant.
The influence of AChE mutants on the development of insecticide resistance in insect pest species has been extensively studied. A large number of DmAChE mutants was generated by changing 13 positions lining the gorge at the choline binding site, the peripheral anionic site, the acyl pocket, and at amino acid positions Y408 and Y409, which play a role in intramolecular signal transduction . The analysis of sensitivity of these enzymes to several carbamate and organophosphate insecticides showed that the majority of amino acid replacements led to a lower sensitivity. Some mutations, e.g. F368L, led to a lower sensitivity to propoxur and to an increased sensitivity to naled, for example. This change in sensitivity varied considerably: F368S led to a 110-fold decrease in sensitivity to propoxur and to a 2.5-fold greater sensitivity to cis-chlorfenvenfos. There were, however, three Drosophila mutants which displayed a greater sensitivity to most tested organophosphates and carbamates. These include DmY408F, DmE107Y and DmY412A (Table 3 ). DmY408F is involved in the stabilisation of the insecticide molecule in the active site by exerting aromatic interactions. It has been suggested that DmE107Y and DmY412A may be part of the peripheral anionic site. Moreover, the substitution of tyrosine by phenylalanine at position 408 led to a mutant which was more sensitive to 12 out of 19 tested insecticides than the wild type (Villatte et al., 1998) .
Boublik et al. have generated several tens of single and multiple DmAChE mutants
and found various amino acid replacements that led to a greater sensitivity to insecticides (Boublik et al., 2002) . The greatest improvement was observed for the sensitivity to dichlorvos for which a combined mutant (DmE69Y, DmY71D) was 300-fold more sensitive than the Drosophila wild-type enzyme. Montesinos et al. have determined the bimolecular rate constants of seven different DmAChE mutants for methamidophos (Montesinos et al., 2000) . The most sensitive mutant displayed a ki value of 2.2 x 10 6 M -1 min -1 ; the wild type DmAChE only reached a ki value of 7.3 x 10 3 M -1 min -1 .
The protein-inhibitor interactions were studied by computer-aided molecular modelling techniques. The protein structure of RbAChE was modelled from the sequence based on the X-ray structure of the homologous Torpedo californica AChE (Figure 2 ). The inhibitors paraoxon and aldicarb were docked to the active site of RbAChE and the effect of mutations on specificity was predicted. According to these studies, Pleiss et al. replaced the acyl pocket residue phenylalanine-295 of rat brain AChE by leucine (Pleiss et al., 1997; Pleiss et al., 1999) . The RbF295L mutation led to a greater sensitivity to all five tested organophosphates and the three tested carbamates. The increase in sensitivity was most pronounced for the bulky ethoprophos (factor of 80). This greater sensitivity was attributed to the enlarged acyl pocket.
To summarise, it can be concluded that mutations, which lead to a greater sensitivity to organophosphates or carbamates are not restricted to a special region of the AChE gorge. Some mutations were found in the acyl pocket, the peripheral anionic site or the choline-binding site of AChE. Most of these mutations were not created with the purpose of producing more sensitive AChE variants for application in biosensors. Instead, they were the result of mechanistic studies on the catalytic reaction with respect to enzyme and insecticide resistance. Most of these mutants were tested with model analytes like paraoxon and DFP and not with organophosphates or carbamates with a low bimolecular rate constant, which cannot yet be detected with AChE-biosensors at the required concentration range (e.g. aldicarb, ethiofencarb, butocarboxim or profenophos).
Biosensor application of recombinant AChE
Recently, the specific features of recombinant AChEs described have received A severe drawback of all methods that are based on the use of a single AChE form only, arises from the observation that each organophosphate and carbamate inhibits the enzyme to a different extent. This renders it virtually impossible to calibrate an unknown mixture of various analytes (of unknown/different concentrations). For example, the inhibition constants for individual organophosphates and carbamates against bovine erythrocyte AChE vary up to a factor of 500 (Herzsprung et al., 1989) .
In practice, paraoxon is generally used for calibration. However, the value of these procedures for assays involving AChE inhibitors of unknown composition raises doubts. On the other hand, all biosensors described so far are based on this mechanism. They provide a sum parameter as signal, which is expressed as total anti-acetylcholinesterase activity. (Bachmann and Schmid, 1999; Bachmann et al., 2000) . The DmAChE variants were selected from a large number of mutants on the basis of displaying an individual sensitivity pattern towards the target analytes. These systems are based on the combination of amperometric multielectrode biosensors with chemometric data analysis of sensor outputs using artificial neural networks. This type of multisensor enabled the quantitative discrimination of paraoxon and carbofuran with a resolution error of 0.4 µg/L for paraoxon and 0.5 µg/L for carbofuran. A lower determination limit of 0.5 µg/L for each analyte (1.8 x 10 -9 M paraoxon, respectively 2.3 x 10 -9 M carbofuran) could be achieved by incorporating mutant DmY408F, which was designed for sensitive insecticide detection by site-directed mutagenesis.
Conclusion
At present, the application of the AChE inhibition test is restricted to only a limited number of analytes because AChE sensitivity to other analytes does not yet meet the standards of sensitivity required. Protein engineering will certainly become increasingly important in the development of biosensors. It is the most promising technique with respect to the design of AChE biosensors that meet the required standards. More sensitive AChE variants and sophisticated multianalyte detection systems are critical issues when it comes to turning AChE biosensors into marketable products. (Ordentlich et al., 1996) Hu F295A 1800 65 830 (Ordentlich et al., 1996) Hu F295L 800 264 940 (Ordentlich et al., 1996) Hu F295L/ F297V 117 340 310 (Ordentlich et al., 1996) Hu E405A 1.9 0.09 1.5 (Ordentlich et al., 1996) Hu G121A 0.085 0.007 (Ordentlich et al., 1998) (Villatte et al., 1998) Dm B08 220 (Montesinos et al., 2000) WT Rb 80 52 0.07 (Pleiss et al., 1999) Rb F295L 550 120 5.6 (Pleiss et al., 1999) WT: wild type; Hu: human AChE, amino acid numbering corresponds to human AChE; HuBChE: human butyrylcholinesterase; Dm: Drosophila melanogaster AChE, amino acid numbering corresponds to DmAChE; Rb: rat brain AChE, amino acid numbering corresponds to RbAChE.
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Figure 2: Complex of wild-type (left) and mutant (right) RbAChE with paraoxon. The catalytic triad (Ser203, His447, Glu334) and the mutation site are displayed in gray and black, respectively.
